This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
zacks-consensus-estimate: Archive
Inspirato Incorporated (ISPO) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Inspirato Incorporated (ISPO) delivered earnings and revenue surprises of -2.44% and +10.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ISPOPositive Net Change VIKPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Marchex (MCHX) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Marchex (MCHX) delivered earnings and revenue surprises of +300.00% and -6.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MCHXPositive Net Change BLINNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CAE (CAE) Matches Q1 Earnings Estimates
by Zacks Equity Research
CAE (CAE) delivered earnings and revenue surprises of 0.00% and -1.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CAENegative Net Change ESLTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
QuickLogic (QUIK) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
QuickLogic (QUIK) delivered earnings and revenue surprises of -28.57% and -7.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
QUIKNegative Net Change CRDONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Webtoon Entertainment (WBTN) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Webtoon (WBTN) delivered earnings and revenue surprises of +250.00% and +2.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
WBTNNegative Net Change PDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Beyond Air (XAIR) delivered earnings and revenue surprises of -2.00% and -1.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
XAIRPositive Net Change HOWLPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Alico (ALCO) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Alico (ALCO) delivered earnings and revenue surprises of -119.27% and -5.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ALCONegative Net Change LMNRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Generation Bio (GBIO) delivered earnings and revenue surprises of -11.43% and -51.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GBIONegative Net Change OCSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
PSQ Holdings, Inc. (PSQH) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
PSQ Holdings, Inc. (PSQH) delivered earnings and revenue surprises of +33.33% and -21.04%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PSQHNegative Net Change PDDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Pixelworks (PXLW) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Pixelworks (PXLW) delivered earnings and revenue surprises of +7.41% and -2.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PXLWNegative Net Change MRVLNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
NeuroPace (NPCE) delivered earnings and revenue surprises of -8.33% and +0.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NPCENegative Net Change ARAYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Surf Air Mobility Inc. (SRFM) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Surf Air Mobility Inc. (SRFM) delivered earnings and revenue surprises of +14.68% and +5.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SRFMNegative Net Change CAAPPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Theravance Biopharma (TBPH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Theravance Bio (TBPH) delivered earnings and revenue surprises of +42.86% and +53.76%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TBPHPositive Net Change MGXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
GCT Semiconductor Holding, Inc. (GCTS) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
GCT Semiconductor Holding, Inc. (GCTS) delivered earnings and revenue surprises of -85.71% and -47.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GCTSNegative Net Change AVGONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Luminar Technologies, Inc. (LAZR) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Luminar Technologies (LAZR) delivered earnings and revenue surprises of -25.21% and -6.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LAZRNegative Net Change INVZPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Verrica Pharmaceuticals (VRCA) delivered earnings and revenue surprises of +102.86% and +154.04%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
VRCANegative Net Change IGCPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
ABSCI CORP (ABSI) delivered earnings and revenue surprises of -26.32% and -74.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ABSINegative Net Change CLNNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of +4.84% and +26.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LYRANegative Net Change VVOSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Lumentum (LITE) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Lumentum (LITE) delivered earnings and revenue surprises of +7.32% and +1.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LITENegative Net Change CIENNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Intapp (INTA) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Intapp (INTA) delivered earnings and revenue surprises of +17.39% and +2.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
INTAPositive Net Change GWREPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Intellicheck Mobilisa, Inc. (IDN) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Intellicheck Mobilisa (IDN) delivered earnings and revenue surprises of 0.00% and +1.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IDNNegative Net Change LAKEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Fate Therapeutics (FATE) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Fate Therapeutics (FATE) delivered earnings and revenue surprises of +17.14% and +190.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FATEPositive Net Change RNAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Editas (EDIT) delivered earnings and revenue surprises of -53.66% and +320.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
EDITPositive Net Change DAREPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Journey Medical (DERM) delivered earnings and revenue surprises of -128.57% and +1.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DERMNegative Net Change PRPHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
TriSalus Life Sciences, Inc. (TLSI) delivered earnings and revenue surprises of -22.73% and +5.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TLSIPositive Net Change MDTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank